(Q77467836)

English

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

scientific article published on 01 August 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J M Buesa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A López-Pousa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Martín

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Antón

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J García del Muro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Bellmunt

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Arranz

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

V Valentí

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

P Escudero

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Menéndez

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Casado

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Poveda

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

871-876

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosing and side-effects of ifosfamide plus mesna

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

The enigma of ifosfamide encephalopathy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide by continuous infusion to prevent encephalopathy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008474802882

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008474802882

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9789610%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77467836&oldid=1566684283"